In the Basis of Hashimoto’s Thyroiditis, to Form Papillary Thyroid Carcinoma, Metastasized and Then to De-Differentiate into Poorly Differentiated Squamous Cell Carcinoma — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
In the Basis of Hashimoto’s Thyroiditis, to Form Papillary Thyroid Carcinoma, Metastasized and Then to De-Differentiate into Poorly Differentiated Squamous Cell Carcinoma
The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
,
The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
,
The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
,
Department of Pathology, Zhanjiang Central People’s Hospital, Zhanjiang, China
,
The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
,
The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
,
The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
,
The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
1 The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
2 The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
3 The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
4 Department of Pathology, Zhanjiang Central People’s Hospital, Zhanjiang, China
5 The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
6 The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
7 The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
8 The Center of Pathological Diagnosis and Research, Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
Thyroid squamous cell carcinoma is very rare. At present, it is limited to case reports. Since the thyroid follicular epithelium is the non-squamous epithelium, how primary squamous cell carcinoma (SCC) of the thyroid occurs is still a controversial issue. Hashimoto’s thyroiditis (HT) is considered to be an independent risk factor for thyroid cancer, under the basis of HT, how tumor cells evolve and develop to papillary thyroid carcinoma (PTC), and particularly to de-differentiate into SCC is elusive. We report a 72-year-old female patient who developed multiple subtypes of PTC on a basis of HT, and finally to de-differentiate into SCC within the local foci of lymph node metastasis. We found that there was a variety of sub-types of PTC in this patient in the background of HT. SCC was found within local lymph node metastasis. Pathomorphology, immunohistochemistry, and molecular pathology have confirmed that the SCC was derived from PTC, and then developed into poorly differentiated SCC and/or anaplastic carcinoma. We also conducted a comprehensive literature review.
Coca-Pelaz, A., Shah, J.P, Hernandez-Prera, J.C., Ghossein, R.A., Rodrigo, J.P., Hartl, D.M., et al. (2020) Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review. Advances in Therapy, 37, 3112-3128. https://doi.org/10.1007/s12325-020-01391-1
Molnár, C., Molnár, S., Bedekovics, J., Mokánszki, A., Gyory, F., Nagy, E., et al. (2019) Thyroid Carcinoma Coexisting with Hashimoto’s Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis. Pathology & Oncology Research, 25, 1191-1197. https://doi.org/10.1007/s12253-019-00580-w
Ferrari, S.M., Fallahi, P., Elia, G., Ragusa, F., Ruffilli, I., Rosaria Paparo, S., et al. (2020) Thyroid Autoimmune Disorders and Cancer. Seminars in Cancer Biology, 64, 135-146. https://doi.org/10.1016/j.semcancer.2019.05.019
Graceffa, G., Patrone, R., Vieni, S., Campanella, S., Calamia, S., Laise, I., et al. (2019) Association between Hashimoto’s Thyroiditis and Papillary Thyroid Carcinoma: A Retrospective Analysis of 305 Patients. BMC Endocrine Disorders, 19, Article No. 26. https://doi.org/10.1186/s12902-019-0351-x
Jackson, D., Handelsman, R.S., Farrá, J.C. and Lew, J.I. (2020) Increased Incidental Thyroid Cancer in Patients with Subclinical Chronic Lymphocytic Thyroiditis. Journal of Surgical Research, 245, 115-118. https://doi.org/10.1016/j.jss.2019.07.025
Paparodis, R.D., Karvounis, E., Bantouna, D., Chourpiliadis, C., Chourpiliadi, H., Livadas, S., et al. (2020) Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis than with Multinodular Goiter or Graves’ Disease. Thyroid, 30, 531-535. https://doi.org/10.1089/thy.2019.0347
Borowczyk, M., Janicki, A., Dworacki, G., Szczepanek-Parulska, E., Danieluk, M., Barnett, J., et al. (2019) Decreased Staging of Differentiated Thyroid Cancer in Patients with Chronic Lymphocytic Thyroiditis. Journal of Endocrinological Investigation, 42, 45-52. https://doi.org/10.1007/s40618-018-0882-4
Orlp, L.R. (2017) WHO Classification of Tumours of Endocrine Organs. 4th Edition, France International Agency for Research on Cancer (IARC), Lyon.
Bongiovanni, M., Sykiotis, G.P., La Rosa, S., Bisig, B., Trimech, M., Missiaglia, E., et al. (2020) Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma. Thyroid, 30, 72-80. https://doi.org/10.1089/thy.2018.0607
Ragazzi, M., Torricelli, F., Donati, B., Ciarrocchi, A., de Biase, D., Tallini, G., et al. (2020) Coexisting Well-Differentiated and Anaplastic Thyroid Carcinoma in the Same Primary Resection Specimen: Immunophenotypic and Genetic Comparison of the Two Components in a Consecutive Series of 13 Cases and a Review of the Literature. Virchows Archiv, 478, 265-281. https://doi.org/10.1007/s00428-020-02891-9
Hernandez-Prera, J.C. (2020) The Evolving Concept of Aggressive Histological Variants of Differentiated Thyroid Cancer. Seminars in Diagnostic Pathology, 37, 228-233. https://doi.org/10.1053/j.semdp.2020.03.002
Limberg, J., Ullmann, T.M., Stefanova, D., Finnerty, B.M., Beninato, T., Fahey III, T.J., et al. (2020) Prognostic Characteristics of Primary Squamous Cell Carcinoma of the Thyroid: A National Cancer Database Analysis. World Journal of Surgery, 44, 348-355. https://doi.org/10.1007/s00268-019-05098-5
Lim, A.E., Sooby, P. and Townsley, R.B. (2020) Primary Thyroid Squamous Cell Carcinoma—A Scottish National Case Series. Scottish Medical Journal, 65, 60-63. https://doi.org/10.1177/0036933020916348
Puccini, M., Roffi, N., Pucci, V., Fiacchini, G., Ugolini, C. and Buccianti, P. (2020) Synchronous Squamous Cell Carcinoma and Papillary Thyroid Carcinoma Arising from the Thyroglossal Duct Remnant: Case Report and a Review of the Literature. SAGE Open Medical Case Reports, 8, 2050313X-2091784X. https://doi.org/10.1177/2050313X20917846
Sun, B.H., Yu, S.T., Ge, J.N. and Lei, S.-T. (2020) Primary Squamous Cell Carcinoma (PSCC) of the Thyroid: A Case Report and Review of the Literature. Gland Surgery, 9, 474-477. https://doi.org/10.21037/gs.2020.02.18
Yang, S., Li, C., Shi, X., Ma, B., Xu, W., Jiang, H., et al. (2019) Primary Squamous Cell Carcinoma in the Thyroid Gland: A Population-Based Analysis Using the SEER Database. World Journal of Surgery, 43, 1249-1255. https://doi.org/10.1007/s00268-019-04906-2
Struller, F., Senne, M., Falch, C., Kirschniak, A., Konigsrainer, A. and Muller, S. (2017) Primary Squamous Cell Carcinoma of the Thyroid: Case Report and Systematic Review of the Literature. International Journal of Surgery Case Reports, 37, 36-40. https://doi.org/10.1016/j.ijscr.2017.06.011
Lichiardopol, C., Surlin, V., Foarfa, M.C., Ghilusi, M.C. and Bondari, S. (2016) Primary Squamous Cell Carcinoma of the Thyroid: A Case Report. Romanian Journal of Morphology and Embryology, 57, 831-836.
Dong, S., Song, X.S., Chen, G. and Liu, J. (2016) Mixed Primary Squamous Cell Carcinoma, Follicular Carcinoma, and Micropapillary Carcinoma of the Thyroid Gland: A Case Report. Auris Nasus Larynx, 43, 455-459. https://doi.org/10.1016/j.anl.2015.10.011
Kallel, S., Kallel, R., Ayadi, S. and Ghorbel, A. (2018) Primary Squamous Cell Carcinoma of the Thyroid Associated with Papillary Thyroid Carcinoma and Hashimoto’s Thyroiditis. European Annals of Otorhinolaryngology, Head and Neck Diseases, 135, 291-293. https://doi.org/10.1016/j.anorl.2018.05.012
Vita, R., Ieni, A., Tuccari, G. and Benvenga, S. (2018) The Increasing Prevalence of Chronic Lymphocytic Thyroiditis in Papillary Microcarcinoma. Reviews in Endocrine and Metabolic Disorders, 19, 301-309. https://doi.org/10.1007/s11154-018-9474-z
Uhliarova, B. and Hajtman, A. (2018) Hashimoto’s Thyroiditis—An Independent Risk Factor for Papillary Carcinoma. Brazilian Journal of Otorhinolaryngology, 84, 729-735. https://doi.org/10.1016/j.bjorl.2017.08.012
Fugazzola, L., Muzza, M., Pogliaghi, G. and Vitale, M. (2020) Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance. Cancers, 12, Article No. 383. https://doi.org/10.3390/cancers12020383
Ho, A.S., Luu, M., Barrios, L., Chen, I., Melany, M., Ali, N., et al. (2020) Incidence and Mortality Risk Spectrum across Aggressive Variants of Papillary Thyroid Carcinoma. JAMA Oncology, 6, 706-713. https://doi.org/10.1001/jamaoncol.2019.6851
Pradhan, D., Sharma, A. and Mohanty, S.K. (2015) Cribriform-Morular Variant of Papillary Thyroid Carcinoma. Pathology—Research and Practice, 211, 712-716. https://doi.org/10.1016/j.prp.2015.04.011
Torrez, M., Braunberger, R.C., Yilmaz, E. and Agarwal, S. (2020) Primary Squamous Cell Carcinoma of Thyroid with a Novel BRAF Mutation and High PDL-1 Expression: A Case Report with Treatment Implications and Review of Literature. Pathology—Research and Practice, 216, Article ID: 153146. https://doi.org/10.1016/j.prp.2020.153146
Pekova, B., Sykorova, V., Dvorakova, S., Vaclavikova, E., Moravcova, J., Katra, R., et al. (2020) RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas. Thyroid, 30, 1771-1780. https://doi.org/10.1089/thy.2019.0802
Pessoa-Pereira, D., Medeiros, M., Lima, V., da Silva Jr., J.C., de Oliveira Cerqueira, T.L., da Silva, I.C., et al. (2019) Association between BRAF (V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma: A Brazilian Single-Centre Case Series. Archives of Endocrinology and Metabolism, 63, 97-106. https://doi.org/10.20945/2359-3997000000120
Moulana, F.I., Priyani, A.A.H., de Silva, M.V.C. and Dassanayake, R.S. (2018) BRAF-Oncogene-Induced Senescence and the Role of Thyroid-Stimulating Hormone Signaling in the Progression of Papillary Thyroid Carcinoma. Hormones and Cancer, 9, 1-11. https://doi.org/10.1007/s12672-017-0315-4
Xing, M., Alzahrani, A.S., Carson, K.A., Shong, Y.K., Kim, T.Y., Elisei, D.V.R., et al. (2015) Association between BRAFV600E Mutation and Recurrence of Papillary Thyroid Cancer. Journal of Clinical Oncology, 33, 42-50. https://doi.org/10.1200/JCO.2014.56.8253
Xing, M., Liu, R., Liu, X., Murugan, A.K., Zhu, G., ZeigerSara Pai, M.A., et al. (2014) BRAFV600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer with Highest Recurrence. Journal of Clinical Oncology, 32, 2718-2726. https://doi.org/10.1200/JCO.2014.55.5094
Haugen, B.R., Alexander, E.K., Bible, K.C., Doherty, G.M., Mandel, S.J., Nikiforov, Y.E., et al. (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26, 1-133. https://doi.org/10.1089/thy.2015.0020
Haugen, B.R. (2017) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What Is New and What Has changed? Cancer, 123, 372-381. https://doi.org/10.1002/cncr.30360
Tiedje, V. and Fagin, J.A. (2020) Therapeutic Breakthroughs for Metastatic Thyroid Cancer. Nature Reviews Endocrinology, 16, 77-78. https://doi.org/10.1038/s41574-019-0307-2
Holoubek, S.A., Yan, H., Khokar, A.H., Kuchta, K.M., Winchester, D.J., Prinz, R.A., et al. (2020) Aggressive Variants of Papillary Thyroid Microcarcinoma Are Associated with High-Risk Features, but Not Decreased Survival. Surgery, 167, 19-27. https://doi.org/10.1016/j.surg.2019.03.030
Filetti, S., Durante, C., Hartl, D., Leboulleux, S., Locati, L.D., Newbold, K., et al. (2019) Thyroid Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 30, 1856-1883. https://doi.org/10.1093/annonc/mdz400
Limberg, J., Ullmann, T.M., Stefanova, D., Buicko, J.L., Finnerty, B.M., Zarnegar, R., et al. (2019) Does Aggressive Variant Histology Without Invasive Features Predict Overall Survival in Papillary Thyroid Cancer? A National Cancer Database Analysis. Annals of Surgery. https://doi.org/10.1097/SLA.0000000000003632
Bongers, P.J., Kluijfhout, W.P., Verzijl, R., Lustgarten, M., Vermeer, M., Goldstein, D.P., et al. (2019) Papillary Thyroid Cancers with Focal Tall Cell Change Are as Aggressive as Tall Cell Variants and Should Not Be Considered as Low-Risk Disease. Annals of Surgical Oncology, 26, 2533-2539. https://doi.org/10.1245/s10434-019-07444-2
Song, E., Jeon, M.J, Oh, H.S., Han, M., Lee, Y.-M., Kim, T.Y., et al. (2018) Do Aggressive Variants of Papillary Thyroid Carcinoma Have Worse Clinical Outcome than classic Papillary Thyroid Carcinoma? European Journal of Endocrinology, 179, 135-142. https://doi.org/10.1530/EJE-17-0991
Zhu, J., Wang, X., Zhang, X., Li, P. and Hou, H. (2015) Clinicopathological Features of Recurrent Papillary Thyroid Cancer. Diagnostic Pathology, 10, Article No. 96. https://doi.org/10.1186/s13000-015-0346-5